Prev：Blocking the LRH-1/LCN2 axis by ML-180, an LRH-1 inverse agonist, ameliorates osteoarthritis via inhibiting the MAPK pathway.(BMU102-5.600)
Next：Baicalin mitigates cardiac hypertrophy and fibrosis by inhibiting the p85a subunit of PI3K.(BMU102-3.900)
